US Financial Advisors’s GSK GSK Stock Holding History

US Financial Advisors’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-388	Closed	-$20K	–	529
2015 Q4	$20K	Buy	+388	New	+$19.8K	0.02%	240

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

US Financial Advisors's GSK Position: Q1 2016 in Review

US Financial Advisors sold out of GSK (GSK) in Q1 2016, closing a stake of 388 shares — an estimated $20K sold.

US Financial Advisors first reported a position in GSK in Q4 2015 and held it in 1 quarter. The position peaked at $20K in Q4 2015. 726 funds tracked by Wall St. Rank hold GSK as of Q1 2016.

US Financial Advisors reported no remaining GSK position as of Q1 2016 after selling out during the quarter.
US Financial Advisors sold 388 GSK shares in Q1 2016, an estimated $20K.
US Financial Advisors first reported a position in GSK in Q4 2015 and held it in 1 quarter.
US Financial Advisors's GSK position peaked at $20K in Q4 2015.
726 funds tracked by Wall St. Rank held GSK as of Q1 2016.

Based on US Financial Advisors's 13F filing for Q1 2016, filed 5 May 2016.